NCT06550427View on ClinicalTrials.gov

Early Assessment of Lymphoma Treatment Response Using Phased Variant Analysis With Next-Generation Sequencing

RecruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

August 9, 2024

Primary Completion Date

July 31, 2027

Study Completion Date

July 31, 2027

Conditions
LymphomaHodgkin LymphomaT-cell LymphomaWaldenstrom Macroglobulinaemia
Interventions
DIAGNOSTIC_TEST

ctDNA analyzed by phased variant

this observational cohort study is to investigate the correlation between ctDNA analyzed by phased variant and the early outcome of the disease.

Trial Locations (1)

Unknown

RECRUITING

National Taiwan University Hospital, Taipei

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER